TY - JOUR AU - Asami, Masahiko PY - 2017 TI - Favorable outcomes for female patients undergoing transcatheter aortic valve replacement? JF - Annals of Translational Medicine; Vol 5, No 16 (August 11, 2017): Annals of Translational Medicine Y2 - 2017 KW - N2 - Transcatheter aortic valve replacement (TAVR) is an established treatment for high surgical risk or inoperable patients with severe aortic stenosis (AS) (1-3). Interestingly, unlike percutaneous coronary intervention (PCI), approximately 50% of patients who undergo TAVR are female, despite the fact that female patients have fewer comorbidities than male patients (4-6). Furthermore, female patients have been found to have favorable outcomes as compared to male patients (5-10). However, to date, it remains unclear why male patients have a higher incidence of mortality after TAVR. Understanding this might help determine the effect of sex differences in patients with severe AS undergoing TAVR and should therefore be evaluated. UR - https://atm.amegroups.org/article/view/14677